Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Cs02 Tablet And Placebo Tablet

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 2 (1)

Trial Status

Completed1
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06692153Not ApplicableWithdrawn

Embecta AID System in Adults With Type 2 Diabetes

NCT03317028Phase 2CompletedPrimary

CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)

Showing all 2 trials

Research Network

Common Treatments

  • Cs02 Tablet And Placebo Tablet1
  • An Aid System1
  • Standard Of Care Sc1

Active Sponsors

  • Center Laboratories, Inc.1
  • Embecta Corp.1
  • Jaeb Center for Health Research1

Top Investigators

Related Conditions

  • Type 2 Dm1
  • T2dm Type 2 Diabetes Mellitus1
  • T2d1
  • T2dm1
  • Type 2 Diabetes1

Activity Timeline